Condition
Idiopathic Ventricular Fibrillation
Total Trials
3
Recruiting
1
Active
1
Completed
0
Key Insights
Highlights
No notable highlights available yet
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 30/100
Termination Rate
0.0%
0 terminated out of 3 trials
Late-Stage Pipeline
33%
1 trials in Phase 3/4
Results Transparency
0%
0 of 0 completed with results
Key Signals
Data Visualizations
Phase Distribution
1Total
P 4 (1)
Trial Status
Unknown1
Enrolling By Invitation1
Recruiting1
Clinical Trials (3)
Showing 3 of 3 trials
NCT07405229Phase 4RecruitingPrimary
MEdical Treatment in Idiopathic Ventricular Fibrillation Patients
NCT06943365Enrolling By Invitation
Role of Anti-TREK-1 Autoantibodies in SCVF
NCT03963271Unknown
Noninvasive Electrocardiographic Imaging for Individuals at Risk for Apparently Idiopathic Ventricular Fibrillation.
Showing all 3 trials